A case of synchronous multiple primary lung adenocarcinomas harboring epidermal growth factor receptor mutation and anaplastic lymphoma kinase rearrangement successfully treated with combination of osimertinib and alectinib

Synchronous multiple primary lung cancers (SMPLC) should be distinguished from intrapulmonary metastasis to define the optimal treatment approach. Epidermal growth factor receptor (EGFR) mutations and anaplastic lymphoma kinase (ALK) rearrangements are typically mutually exclusive and the co-existen...

Descripción completa

Detalles Bibliográficos
Autores principales: Inoue, Yukihisa, Matsubara, Osamu, Ohira, Yumi, Endo, Satoshi, Jinn, Yasuto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348148/
https://www.ncbi.nlm.nih.gov/pubmed/34401266
http://dx.doi.org/10.1016/j.rmcr.2021.101418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348148/
https://www.ncbi.nlm.nih.gov/pubmed/34401266
http://dx.doi.org/10.1016/j.rmcr.2021.101418

Ejemplares similares